Pharmaco-genetic therapeutics targeting parvalbumin neurons attenuate temporal lobe epilepsy
Temporal lobe epilepsy (TLE) is the most common type of epilepsy and is often medically refractory. Previous studies suggest that selective pharmaco-genetic inhibition of pyramidal neurons has therapeutic value for the treatment of epilepsy, however there is a risk of disrupting normal physical func...
שמור ב:
| Principais autores: | , , , , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2018-09-01
|
| סדרה: | Neurobiology of Disease |
| נושאים: | |
| גישה מקוונת: | http://www.sciencedirect.com/science/article/pii/S0969996118301815 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
